logo conference-reports

Congres verslagen

BROUGHT TO YOU BY MSD_HIV logo MSD_HIV

HIV-Glasgow 2018 – MK-8591 efficacy against diverse HIV-1 subtypes and NRTI-resistant clinical isolates

Dr Jay Grobler presents the latest data on MK-8591, a novel nucleoside with a unique mechanism of action. This first-in-class nucleoside reverse transcriptase translocation inhibitor (NRTTI) inhibits HIV replication through multiple mechanisms.
De bron die u probeert te openen is alleen beschikbaar voor geregistreerde gebruikers. Om verder te gaan kunt u inloggen of een GRATIS univadis ® account aanmaken.